Also trades as: IPD.AX (ASX) · $vol 0M
IPDQF OTC
ImpediMed Limited
1W: -18.2%
1M: -15.9%
3M: -18.2%
YTD: -81.8%
1Y: -83.3%
3Y: -95.9%
5Y: -94.9%
$0.00
-0.00 (-18.18%)
Weekly Expected Move ±22.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$35M
-16.9% ▼
5Y CAGR: +0.2%
Total Liabilities
$24M
+15.5% ▲
5Y CAGR: +23.0%
Shareholders Equity
$10M
-50.4% ▼
5Y CAGR: -16.8%
Cash & Investments
$15M
-31.2% ▼
5Y CAGR: -5.0%
Total Debt
$508K
-96.5% ▼
5Y CAGR: +1.4%
Net Debt
-$15M
-91.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $41M | $46M | $25M | $22M | $15M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $41M | $46M | $25M | $22M | $15M |
| Net Receivables | $3M | $4M | $2M | $3M | $5M |
| Inventory | $926K | $810K | $759K | $861K | $2M |
| Other Current Assets | $2M | $2M | $555K | $689K | $1M |
| Total Current Assets | $47M | $52M | $29M | $28M | $23M |
| Property, Plant & Equip. | $418K | $2M | $1M | $883K | $646K |
| Goodwill & Intangibles | $11M | $18M | $16M | $13M | $10M |
| Long-Term Investments | $75K | $78K | $54K | $65K | $292K |
| Other Non-Current Assets | $180K | -$17M | $0 | $235K | $24K |
| Total Non-Current Assets | $12M | $17M | $18M | $14M | $11M |
| Total Assets | $59M | $69M | $47M | $42M | $35M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $1M | $1M | $1M | $1M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $296K |
| Deferred Revenue | $4M | $1M | $1M | $0 | $0 |
| Other Current Liabilities | -$3M | $59K | $67K | $4M | $4M |
| Total Current Liabilities | $7M | $6M | $5M | $6M | $6M |
| Long-Term Debt | $0 | $0 | $0 | $14M | $0 |
| Other Non-Current Liab. | $53K | $442K | $776K | $1M | $18M |
| Total Non-Current Liabilities | $413K | $2M | $2M | $16M | $18M |
| Total Liabilities | $8M | $8M | $6M | $21M | $24M |
| — Equity — | |||||
| Common Stock | $308M | $336M | $336M | $336M | $349M |
| Retained Earnings | -$291M | -$311M | -$331M | -$354M | -$379M |
| Accumulated OCI | $34M | $36M | $36M | $39M | $39M |
| Total Stockholders Equity | $51M | $61M | $41M | $20M | $10M |
| Total Liabilities & Equity | $59M | $69M | $47M | $42M | $35M |
| — Key Metrics — | |||||
| Total Debt | $170K | $1M | $1M | $14M | $508K |
| Net Debt | -$41M | -$44M | -$23M | -$8M | -$15M |
| Total Investments | $75K | $78K | $54K | $65K | $292K |